Qube Research & Technologies (QRT)’s Ionis Pharmaceuticals IONS Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.22M	Buy	+42,856	New	+$3.38M	﹤0.01%	1894
2023 Q1	–	Sell	-330,724	Closed	-$12.5M	–	2772
2022 Q4	$12.5M	Buy	330,724 +319,027	+2,727%	+$13.4M	0.07%	416
2022 Q3	$517K	Buy	+11,697	New	+$493K	﹤0.01%	1454
2020 Q4	–	Sell	-131,618	Closed	-$6.25M	–	1997
2020 Q3	$6.25M	Buy	+131,618	New	+$7.31M	0.09%	295
2020 Q2	–	Sell	-11,225	Closed	-$531K	–	1853
2020 Q1	$531K	Buy	11,225 +5,508	+96%	+$307K	0.02%	551
2019 Q4	$345K	Buy	+5,717	New	+$341K	0.01%	1153

Other funds holding IONS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Qube Research & Technologies (QRT)'s IONS Position: Q1 2026 in Review

Qube Research & Technologies (QRT) opened a new position in Ionis Pharmaceuticals (IONS) in Q1 2026: 42,856 shares worth $3.22M. The stake represents ﹤0.01% of the portfolio and ranks #1894 among its holdings. This is a return to the name: Qube Research & Technologies (QRT) previously reported a position in IONS as recently as Q4 2022.

Qube Research & Technologies (QRT) first reported a position in IONS in Q4 2019 and has held it in 6 quarters since. The position peaked at $12.5M in Q4 2022. 493 funds tracked by Wall St. Rank hold IONS as of Q1 2026.

Qube Research & Technologies (QRT) held 42,856 shares of Ionis Pharmaceuticals worth $3.22M as of Q1 2026.
Ionis Pharmaceuticals was a new Qube Research & Technologies (QRT) position in Q1 2026.
Ionis Pharmaceuticals made up ﹤0.01% of Qube Research & Technologies (QRT)'s portfolio in Q1 2026, its #1894 holding.
Qube Research & Technologies (QRT) first reported a position in Ionis Pharmaceuticals in Q4 2019 and has held it in 6 quarters since.
Qube Research & Technologies (QRT)'s Ionis Pharmaceuticals position peaked at $12.5M in Q4 2022.
493 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2026, filed 15 May 2026.